NPS

0.135

(%)

TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A))

NOVA PHARMA SOLUTIONS BERHAD

Type Announcement
Subject TAKE-OVERS & MERGERS (PARAGRAPH/RULE 9.19 (47A))
Description
NOVA PHARMA SOLUTIONS BERHAD ("NPS" OR "THE COMPANY")

UNCONDITIONAL MANDATORY TAKE-OVER OFFER FROM KENANGA INVESTMENT BANK BERHAD ("KENANGA IB") ON BEHALF OF SOUTHERN SCORE BUILDERS BERHAD ("SSBB" OR "THE OFFEROR") TO ACQUIRE ALL THE REMAINING ORDINARY SHARES IN NPS NOT ALREADY HELD BY THE OFFEROR AND THE PERSONS ACTING IN CONCERT WITH IT ("OFFER SHARE(S)") FOR A CASH CONSIDERATION OF RM0.37 PER OFFER SHARE ("OFFER")

Unless otherwise stated, all abbreviations used herein shall have the same meaning as defined in the offer document dated 12 January 2026 ("Offer Document").

 

We wish to announce that the Company had on 23 January 2026, received a press release from Kenanga IB, on behalf of the Offeror, informing that as at 5.00 p.m. (Malaysian time) on Friday, 23 January 2026, the Offeror has received valid acceptances in respect of the Offer Shares which resulted in the Offeror and its PACs holding not less than 90% of the total issued shares in NPS.

 

As such, the Offeror will procure NPS to take the requisite steps to withdraw its listing status from the Official List of Bursa Securities, in accordance with Rule 8.07 and Rule 8.08 of the Listing Requirements.

 

In accordance with paragraph 13.01 of the Rules, the level of acceptances of the Offer as at 5.00 p.m. (Malaysian time) on Friday, 23 January 2026 is set out in the attached press release.

 

Notwithstanding the above, as disclosed in the Offer Document dated 12 January 2026, the Offer will remain open for acceptances until 5.00 p.m. (Malaysian time) on Wednesday, 4 February 2026.

 

 

This announcement is dated 23 January 2026.




Please refer attachment below.

Attachments

Press Notice (23.1.2026).pdf
253.8 kB



Announcement Info

Company Name NOVA PHARMA SOLUTIONS BERHAD
Stock Name NPS
Date Announced 23 Jan 2026
Category General Announcement for PLC
Reference Number GA1-22012026-00030